Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples